|
NSUN3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.283800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.856800E-01 |
| Normal-vs-Stage2 |
2.176800E-01 |
| Normal-vs-Stage3 |
8.062000E-01 |
| Normal-vs-Stage4 |
1.054340E-02 |
| Stage1-vs-Stage2 |
7.784100E-02 |
| Stage1-vs-Stage3 |
6.694400E-01 |
| Stage1-vs-Stage4 |
1.107820E-01 |
| Stage2-vs-Stage3 |
4.406200E-01 |
| Stage2-vs-Stage4 |
3.873600E-02 |
| Stage3-vs-Stage4 |
8.503800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.829600E-01 |
| Normal-vs-AfricanAmerican |
4.354000E-01 |
| Normal-vs-Asian |
9.106200E-01 |
| Caucasian-vs-AfricanAmerican |
1.996220E-01 |
| Caucasian-vs-Asian |
9.426600E-01 |
| AfricanAmerican-vs-Asian |
6.731200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.802200E-01 |
| Normal-vs-Female |
7.760100E-02 |
| Male-vs-Female |
3.614200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.593400E-01 |
| Normal-vs-Extreme_Weight |
1.943410E-01 |
| Normal-vs-Obese |
7.376600E-01 |
| Normal-vs-Extreme_Obese |
2.924600E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.718000E-01 |
| Normal_Weight-vs-Obese |
7.805400E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.114600E-01 |
| Extreme_Weight-vs-Obese |
4.063400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.940810E-01 |
| Obese-vs-Extreme_Obese |
2.636600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.054000E-01 |
| Normal-vs-Age(41-60Yrs) |
8.700400E-01 |
| Normal-vs-Age(61-80Yrs) |
5.620800E-01 |
| Normal-vs-Age(81-100Yrs) |
5.474100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.169200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.460400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.323900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.576200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.338200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.901780E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.049200E-01 |
| Normal-VS-Type2 PRCC |
7.370000E-01 |
| Normal-VS-KIRP CIMP |
9.990800E-01 |
| Normal-VS-Unclassified PRCC |
1.951250E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.353200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.470600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.902600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.818200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.464590E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.145800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.776800E-01 |
| Normal-vs-N1 |
7.011200E-01 |
| Normal-vs-N2 |
4.754000E-01 |
| N0-vs-N1 |
3.670400E-01 |
| N0-vs-N2 |
6.107800E-01 |
| N1-vs-N2 |
4.718200E-01 |
|
|
